Short Interest in Ainos, Inc. (NASDAQ:AIMD) Expands By 289.3%

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 91,823 shares, an increase of 289.3% from the May 14th total of 23,588 shares. Based on an average daily volume of 2,248,715 shares, the short-interest ratio is presently 0.0 days. Currently, 1.2% of the company’s stock are short sold.

Insiders Place Their Bets

In other news, Director Ting-Chuan Lee sold 109,988 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $1.90, for a total transaction of $208,977.20. Following the transaction, the director directly owned 807,417 shares of the company’s stock, valued at $1,534,092.30. This represents a 11.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Chun-Jung Tsai sold 27,718 shares of the stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $1.87, for a total value of $51,832.66. Following the sale, the director directly owned 658,199 shares in the company, valued at $1,230,832.13. This trade represents a 4.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders acquired 7,800 shares of company stock valued at $15,946 and sold 179,788 shares valued at $359,247. Corporate insiders own 9.79% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Two Sigma Investments LP bought a new position in shares of Ainos during the 3rd quarter valued at approximately $80,000. Renaissance Technologies LLC raised its stake in Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after acquiring an additional 7,700 shares during the period. DRW Securities LLC lifted its holdings in Ainos by 272.6% during the fourth quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after purchasing an additional 48,439 shares in the last quarter. Finally, Mariner LLC purchased a new stake in shares of Ainos in the fourth quarter worth $37,000.

Ainos Stock Performance

NASDAQ:AIMD traded down $0.01 on Thursday, hitting $1.88. The stock had a trading volume of 1,249 shares, compared to its average volume of 552,587. The business’s 50-day simple moving average is $1.82 and its two-hundred day simple moving average is $1.81. The stock has a market cap of $16.03 million, a price-to-earnings ratio of -0.65 and a beta of 2.41. Ainos has a 52-week low of $1.26 and a 52-week high of $4.50. The company has a quick ratio of 0.50, a current ratio of 0.55 and a debt-to-equity ratio of 1.58.

Ainos (NASDAQ:AIMD) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Ainos presently has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical?stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI?401, is an inhaled formulation of ibuprofen in a dry powder format.